Jagsonpal Pharmaceuticals Schedules Board Meeting for Q2 Earnings on 28th Oct'26
Jagsonpal Pharmaceuticals Ltd 路 Intimation 路 28 Oct 2026, 5:30 am
Jagsonpal Pharmaceuticals Schedules Board Meeting for Q2 Earnings on 28th Oct'26 Jagsonpal Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 28th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended 30th Sep'26. Additionally, the company's trading window for dealing in its securities will remain closed until 30th Oct'26, in continuation of its prior intimation dated 25th Sep'26.
Original exchange filing (PDF)
More announcements from Jagsonpal Pharmaceuticals Ltd
- Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29, 2026 at 2:00 P.M 路 03 Nov 2026
- Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference call on October 29, 2026 at 02:00 P.M. 路 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter September 30, 2026 路 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter ended September 30, 2026. 路 29 Oct 2026
- Unaudited Financial Results (Standalone & Consolidated for the quarter and half year ended September 30, 2026. 路 28 Oct 2026
- Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Outcome of Board Meeting held on October 28, 2026 along with Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30, 2026 路 28 Oct 2026
- JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 28 Oct 2026
